Alivus Life Sciences Ltd header image

Alivus Life Sciences Ltd

543322

Equity

ISIN INE03Q201024 / Valor 112824626

Bombay Stock Exchange Ltd. (Mumbai) (2026-10-08)
INR 1,337.75-2.38%

Alivus Life Sciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alivus Life Sciences Ltd is a life‑sciences company focused on developing and bringing biomedical technologies and services to the healthcare market. Its operations typically span early‑stage research and development through productization, with activities that can include preclinical and clinical programs, diagnostic or therapeutic product development, and provision of research or manufacturing services to partners. The company’s commercial strategy is built around developing proprietary intellectual property, pursuing necessary regulatory clearances, and generating revenue through product sales, service contracts and strategic collaborations or licensing agreements to scale distribution into clinical, laboratory and specialist care channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

45.4%1Y
114%3Y
99.4%5Y

Performance

30.1%1Y
35.7%3Y
32.4%5Y

Volatility

Market cap

1701 M

Market cap (USD)

Daily traded volume (Shares)

5,465

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.46%USD 119.47
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.94%EUR 5.05
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 105.96
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.01%USD 28.06
Harrow Inc
Harrow Inc Harrow Inc Valor: 45675535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%USD 30.52
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%USD 94.32
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 387.12
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 16.37
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 7.96
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 0.89